For laboratory research onlyPreview · No live payments
VEELYONLABLABORATORY RESEARCH
2 FOR 1Lower-priced units free · or choose FALL40 for 40% offExplore offers ↗
Veelyon Lab / Product referenceBack to product ↗

Cagrilintide

10 mg · Peptides

Cagrilintide is a single-format listing: a nominal 10 mg vial. The source report names Cagrilintide; its identity, purity result and analytical method can be reviewed together below.

Compound
Cagrilintide
Nominal format
10 mg
Presentation
Research vial
Intended use
Laboratory research only
CAS, as reported
1415456-99-3
Molecular weight, as reported
4408.258 g/mol
Availability
To be confirmed before launch
This is a product reference sheet, not a Certificate of Analysis.
Monarch Lab source report

Reported purity.

99.91%UHPLC with MS
Source sample result

BioRegen analysis, published by Monarch Lab. Purity is reported for the source sample.

Source report
#13942
Source lot
Not stated
Date on source report
09/04/26
Format stated in report
10 mg
Measured amount
Not stated in report
Identity result
Cagrilintide
Source specification
>99% purity
Full analytical fields
Heavy metals
Not stated in report
Sterility
Not stated in report
Endotoxin
Not stated in report

Missing test results are not treated as passed tests.

Research use only.

For qualified laboratory research and educational evaluation only. Not for human, veterinary or food use. These materials are not intended to diagnose, treat, cure or prevent disease. Scientific references, where provided, offer research context; they are not medical advice or evidence of therapeutic suitability. Purchasers are responsible for qualified handling and compliance with applicable requirements.

Veelyon Lab notes

New compounds.
New source reports.

Get Veelyon Lab catalog updates, newly published documents and occasional offers by email.

Your cart

Clear local demo data?

This removes your cart, favorites, latest simulated order and offer preference from this browser. This action cannot be undone. Your newsletter subscription is not affected.